Ausgabe 4/2008
Immunotherapy for cancer treatment, ASCO 2008 – Highlights
Inhalt (19 Artikel)
Review
Alemtuzumab in chronic lymphocytic leukaemia, other lymphoproliferative disease and autoimmune disorders
M. Fiegl, G. Gastl, G. Hopfinger, K. Eigenberger, A. Zabernigg, T. Schenk, F. Falkner, A. Falkner, S. Sodia, M. Doubek, Y. Brychtova, A. Panovska, R. Greil, J. Mayer
Review
Current status of peptide vaccines for cancer immunotherapy in malignant myeloid diseases
J. Greiner, M. Schmitt
Special Article-Review
Treatment of metastatic breast cancer: a historical perspective
C. C. Zielinski
Basic Research-Review
Gene expression analyses in acute myeloid leukaemia (AML): current status and perspectives
U. Bacher, A. Kohlmann, C. Haferlach, W. Kern, S. Schnittger, T. Haferlach
ASCO Update
Latest progress in treatment of gynaecological cancers
A. G. Zeimet, D. Reimer, C. Marth
ASCO Update
"Not only presidential candidates from Illinois" Haematology news from ASCO 2008
W. Willenbacher
Original Report
The detection of circulating tumour cells in blood of metastatic breast cancer patients is of prognostic relevance
O. Zach, B. Zellhofer, M. Födermayr, H. Kasparu, M. Girschikofsky, W. Hehenwarter, H. Hauser, R. Függer, W. Havlicek, D. Lutz
Announcement